| abstract |
Described herein are compounds of formula (I) and methods of treating disorders by administering a compound of formula (I). Examples of disorders include neoplastic disorders, adipocyte related disorders, neurodegenerative disorders and metabolic disorders. The present invention relates to substituted heterocyclyl compounds, compositions comprising the compounds, and methods of using the compounds and compositions. The compounds and compositions containing them are useful for treating diseases or disease symptoms mediated by sirtuins such as SIRT1, mediated deacetylation. |